Viewing nowBonel Tablet 35 mg (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

MFDS item code 200713910 · Notified 2007.12.31 · Insurance code 649804340
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
This tablet is used for the treatment and prevention of osteoporosis in postmenopausal women and men.
Adults: Administer 35 mg of risedronate sodium orally once weekly. Older adults: No dosage adjustment is necessary in older adults (over 60 years of age), since the bioavailability and pharmacodynamics of this drug are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. Food interferes with the absorption of this drug. To ensure adequate absorption, take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption of this drug. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take a dose on the scheduled dosing day, take it the next morning when remembered. Take the next dose on the originally scheduled dosing day. Do not take 2 tablets on the same day.
Children under 18 years of age: Safety and efficacy have not been established.
This medication may irritate the gastric mucosa, so anyone with esophageal or gastric disorders should consult a doctor before use. Special caution is needed for patients with Barrett's esophagus, dysphagia, esophageal diseases, gastritis, duodenitis, or ulcers. After ingestion, do not lie down for at least 30 minutes and take the medication with a sufficient amount of water while maintaining an upright posture. Serious side effects such as esophagitis or esophageal ulcers may occur rarely; therefore, if symptoms such as dysphagia, chest pain, or heartburn appear, immediately discontinue use and consult a healthcare professional. Patients with esophageal motility disorders, hypocalcemia, pregnant or breastfeeding women, and those with severe renal dysfunction should not take this medication. Patients with a genetic condition that prevents the breakdown of lactose should also avoid this medication. During the use of this drug, it is important to ensure adequate calcium and vitamin D intake, and supplementation may be needed for those undergoing long-term corticosteroid treatment. Bisphosphonate medications can cause rare side effects such as osteonecrosis of the jaw or atypical fractures; thus, oral hygiene and regular dental check-ups are necessary. When taken with other drugs, absorption may be affected, particularly those containing calcium, magnesium, or iron, so a gap of at least 2 hours should be maintained between doses. Pregnant and breastfeeding women should avoid using this medication and consult a doctor if necessary. Safety in children under 18 years has not been established, so use is not recommended. Overdose may lead to hypocalcemia; if symptoms occur, visit a medical facility immediately and calcium supplementation treatment may be administered if needed. This medication should be kept out of the reach of children, and it's important not to transfer it to other containers to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is advisable to keep it at room temperature that is not too hot or too cold. Proper storage will help maintain the efficacy of the drug for a longer period.
Pale orange rectangular film-coated tablets
4 tablets (4 tablets/PTP X 1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.